{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T08:50:53Z","timestamp":1764060653011,"version":"3.40.5"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.ejphar.2015.04.033","type":"journal-article","created":{"date-parts":[[2015,5,2]],"date-time":"2015-05-02T20:50:36Z","timestamp":1430599836000},"page":"36-43","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["A novel water-soluble benzothiazole derivative BD926 inhibits human activated T cell proliferation by down-regulating the STAT5 activation"],"prefix":"10.1016","volume":"761","author":[{"given":"Yang","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8258-5123","authenticated-orcid":false,"given":"Hua","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xing-Yan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min-Hui","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6815-8395","authenticated-orcid":false,"given":"Tai","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan-Tang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-Xia","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Mei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng-Liang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2015.04.033_bib1","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/ardp.200900195","article-title":"Stereoselective synthesis and antiviral activity of (1E,2Z,3E)-1-(piperidin-1-yl)-1-(arylhydrazono)-2-[(benzoyl\/benzothiazol-2-oyl)hy drazono]-4-(aryl(1))but-3-enes","volume":"343","author":"Abdel-Aziza","year":"2010","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.ejphar.2015.04.033_bib2","doi-asserted-by":"crossref","first-page":"4113","DOI":"10.1016\/S0021-9258(18)53587-0","article-title":"Independent regulation of human D-type cyclin gene expression during G1 phase in primary human T lymphocytes","volume":"268","author":"Ajchenbaum","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2015.04.033_bib3","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.5012\/bkcs.2010.31.5.1135","article-title":"Synthesis, spectral and antimicrobial studies of some N (2)-substituted tetrahydroindazoles","volume":"31","author":"Amirthaganesan","year":"2010","journal-title":"Bull. Korean Chem. Soc."},{"key":"10.1016\/j.ejphar.2015.04.033_bib4","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.0105-2896.2009.00859.x","article-title":"Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis","volume":"233","author":"Bartok","year":"2010","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.ejphar.2015.04.033_bib5","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/369756a0","article-title":"A mammalian protein targeted by G1-arresting rapamycin-receptor complex","volume":"369","author":"Brown","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2015.04.033_bib6","doi-asserted-by":"crossref","first-page":"5296","DOI":"10.1021\/jo101275y","article-title":"Characterization of the 4-(benzothiazol-2-yl)phenylnitrenium ion from a putative metabolite of a model antitumor drug","volume":"75","author":"Chakraborty","year":"2010","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.ejphar.2015.04.033_bib7","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1126\/science.1087061","article-title":"Prevention of organ allograft rejection by a specific Janus kinase 3 inhibitor","volume":"302","author":"Changelian","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2015.04.033_bib8","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1248\/cpb.37.2971","article-title":"Imidazo[2,1-b]benzothiazoles. II. Synthesis and antiinflammatory activity of some imidazo[2,1-b]benzothiazoles","volume":"37","author":"El-Shorbagi","year":"1989","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.ejphar.2015.04.033_bib9","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1056\/NEJMra033540","article-title":"Immunosuppressive drugs for kidney transplantation","volume":"351","author":"Halloran","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2015.04.033_bib10","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/jemt.1090","article-title":"Immunopathogenesis of delayed-type hypersensitivity","volume":"53","author":"Kobayashi","year":"2001","journal-title":"Microsc. Res. Tech."},{"key":"10.1016\/j.ejphar.2015.04.033_bib11","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1002\/1529-0131(200011)43:11<2455::AID-ANR12>3.0.CO;2-K","article-title":"Increased interleukin-17 production in patients with systemic sclerosis","volume":"43","author":"Kurasawa","year":"2000","journal-title":"Arthr. Rheum."},{"key":"10.1016\/j.ejphar.2015.04.033_bib12","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/nri3220","article-title":"Immunotherapy: therapeutic targeting of IL-17 for psoriasis","volume":"12","author":"Leavy","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ejphar.2015.04.033_bib13","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/0092-8674(91)90124-H","article-title":"Calcineurin is a common target of cyclophilin\u2013cyclosporin A and FKBP-FK506 complexes","volume":"66","author":"Liu","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2015.04.033_bib14","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1476-5381.2012.02172.x","article-title":"BD750, a benzothiazole derivative, inhibits T cell proliferation by affecting the JAK3\/STAT5 signalling pathway","volume":"168","author":"Liu","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2015.04.033_bib15","doi-asserted-by":"crossref","first-page":"6275","DOI":"10.4049\/jimmunol.154.12.6275","article-title":"Regulation of synthesis and activity of the PLSTIRE protein (cyclin-dependent kinase 6 (cdk6)), a major cyclin D-associated cdk4 homologue in normal human T lymphocytes","volume":"154","author":"Lucas","year":"1995","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2015.04.033_bib16","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.2165\/11319260-000000000-00000","article-title":"Immunosuppressive drugs in kidney transplantation: impact on patient survival, and incidence of cardiovascular disease, malignancy and infection","volume":"69","author":"Marcen","year":"2009","journal-title":"Drugs"},{"key":"10.1016\/j.ejphar.2015.04.033_bib17","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1021\/jm00153a014","article-title":"Imidazo[2,1-b]benzothiazoles. 2. New immunosuppressive agents","volume":"29","author":"Mase","year":"1986","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2015.04.033_bib18","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0223-5234(88)90205-X","article-title":"Imidazo [2, 1-b] benzothiazoles 3: syntheses and immunosuppressive activities of 2-(m-acyloxyphenyl) imidazo [2, 1-b] benzothiazoles","volume":"23","author":"Mase","year":"1988","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejphar.2015.04.033_bib19","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1002\/1529-0131(200109)44:9<2097::AID-ART360>3.0.CO;2-6","article-title":"Predominance of Th1 immune response in diffuse proliferative lupus nephritis","volume":"44","author":"Masutani","year":"2001","journal-title":"Arthr. Rheum."},{"key":"10.1016\/j.ejphar.2015.04.033_bib20","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1208\/s12249-012-9787-2","article-title":"Design of lipid-based formulations for oral administration of poorly water-soluble drug fenofibrate: effects of digestion","volume":"13","author":"Mohsin","year":"2012","journal-title":"AAPS Pharm. Sci. Tech."},{"key":"10.1016\/j.ejphar.2015.04.033_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/CS20100163","article-title":"Psoriasis: from pathogenesis to novel therapeutic approaches","volume":"120","author":"Monteleone","year":"2011","journal-title":"Clin. Sci."},{"key":"10.1016\/j.ejphar.2015.04.033_bib22","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S1074-7613(00)80025-4","article-title":"Stat5 is required for IL-2-induced cell cycle progression of peripheral T cells","volume":"10","author":"Moriggl","year":"1999","journal-title":"Immunity"},{"key":"10.1016\/j.ejphar.2015.04.033_bib23","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ijpharm.2013.03.054","article-title":"Lipid-based formulations for oral administration of poorly water-soluble drugs","volume":"453","author":"Mu","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejphar.2015.04.033_bib24","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1600-065X.2008.00648.x","article-title":"The role and therapeutic implications of fibroblast-like synoviocytes in inflammation and cartilage erosion in rheumatoid arthritis","volume":"223","author":"Noss","year":"2008","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.ejphar.2015.04.033_bib25","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.0105-2896.2005.00220.x","article-title":"Jak3, severe combined immunodeficiency, and a new class of immunosuppressive drugs","volume":"203","author":"Pesu","year":"2005","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.ejphar.2015.04.033_bib26","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1016\/j.transproceed.2011.06.025","article-title":"Present and future of immunosuppressive therapy in kidney transplantation","volume":"43","author":"Ponticelli","year":"2011","journal-title":"Transpl. Proc."},{"key":"10.1016\/j.ejphar.2015.04.033_bib27","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ejps.2006.04.016","article-title":"Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system","volume":"29","author":"Pouton","year":"2006","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejphar.2015.04.033_bib28","doi-asserted-by":"crossref","first-page":"5638","DOI":"10.4049\/jimmunol.1200936","article-title":"IL-10 produced by induced regulatory T cells (iTregs) controls colitis and pathogenic ex-iTregs during immunotherapy","volume":"189","author":"Schmitt","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2015.04.033_bib29","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1097\/00007890-199511270-00015","article-title":"Mycophenolic acid, an inhibitor of IMP dehydrogenase that is also an immunosuppressive agent, suppresses the cytokine-induced nitric oxide production in mouse and rat vascular endothelial cells","volume":"60","author":"Senda","year":"1995","journal-title":"Transplantation"},{"key":"10.1016\/j.ejphar.2015.04.033_bib30","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.ejmech.2011.10.027","article-title":"Synthesis of novel cinnamanilides as potential immunosuppressive agents","volume":"47","author":"Shi","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejphar.2015.04.033_bib31","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2478\/v10007-009-0031-x","article-title":"Synthesis and preliminary screening of benzothiazol-2-yl thiadiazole derivatives for anticonvulsant activity","volume":"59","author":"Siddiqui","year":"2009","journal-title":"Acta Pharm."},{"issue":"Suppl 33","key":"10.1016\/j.ejphar.2015.04.033_bib32","first-page":"S76","article-title":"Immunosuppressive drugs and renal transplantation","volume":"22","author":"Stallone","year":"2005","journal-title":"G Ital Nefrol"},{"key":"10.1016\/j.ejphar.2015.04.033_bib33","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1024\/0040-5930\/a000230","article-title":"Immunosuppressive drugs\u2013how they work, their side effects and interactions","volume":"68","author":"Stucker","year":"2011","journal-title":"Ther. Umsch."},{"key":"10.1016\/j.ejphar.2015.04.033_bib34","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1016\/j.bmcl.2009.02.037","article-title":"Discovery of [3-(4,5,7-trifluoro-benzothiazol-2-ylmethyl)-pyrrolo[2,3-b]pyridin-1-yl]acetic acids as highly potent and selective inhibitors of aldose reductase for treatment of chronic diabetic complications","volume":"19","author":"Van Zandt","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejphar.2015.04.033_bib35","doi-asserted-by":"crossref","first-page":"3810","DOI":"10.1073\/pnas.95.7.3810","article-title":"Cytokine-induced survival of activated T cells in vitro and in vivo","volume":"95","author":"Vella","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejphar.2015.04.033_bib36","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1007\/s00894-011-1299-6","article-title":"Molecular simulation of a series of benzothiazole PI3Kalpha inhibitors: probing the relationship between structural features, anti-tumor potency and selectivity","volume":"18","author":"Wang","year":"2012","journal-title":"J. Mol. Model."},{"key":"10.1016\/j.ejphar.2015.04.033_bib37","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.immuni.2009.05.001","article-title":"Plasticity of CD4+ T cell lineage differentiation","volume":"30","author":"Zhou","year":"2009","journal-title":"Immunity"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299915003775?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299915003775?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T01:06:25Z","timestamp":1691629585000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299915003775"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":37,"alternative-id":["S0014299915003775"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2015.04.033","relation":{},"ISSN":["0014-2999"],"issn-type":[{"type":"print","value":"0014-2999"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel water-soluble benzothiazole derivative BD926 inhibits human activated T cell proliferation by down-regulating the STAT5 activation","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2015.04.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}